Login / Signup

Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines.

Aruna KamineniV Paul Doria-RoseJessica ChubakJohn M InadomiDouglas A CorleyJennifer S HaasSarah C KobrinRachel L WinerJennifer Elston LafataElisabeth F BeaberJoshua S YudkinYingye ZhengCelette Sugg SkinnerJoanne E SchottingerDebra P RitzwollerJennifer M CroswellAndrea N Burnett-Hartman
Published in: Annals of internal medicine (2022)
National Cancer Institute.
Keyphrases
  • papillary thyroid
  • squamous cell
  • clinical practice
  • adverse drug
  • lymph node metastasis
  • emergency department